KIT
Drug: Dasatinib
Cancer code: LAML
Cancer type: acute_myeloid_leukaemia
Drug treatment table
| Cell line ID |
Cell line name |
Mutation in substructure |
IC50(uM) |
| SIDM01005 | KASUMI-1 | A_loop (822) | 12.8718 |
| SIDM00785 | KG-1 | None | 3.9124 |
| SIDM01019 | KMOE-2 | None | 18.3851 |
| SIDM00441 | ML-2 | None | 10.3013 |
| SIDM01023 | MONO-MAC-6 | None | 1.0082 |
| SIDM00576 | NKM-1 | None | 0.8684 |
| SIDM00580 | NOMO-1 | None | 27.1985 |
| SIDM00363 | P31-FUJ | None | 8.193 |
| SIDM00396 | SIG-M5 | None | 2.2048 |
| SIDM01172 | THP-1 | None | 9.0729 |
| SIDM00467 | QIMR-WIL | None | 0.4533 |
| SIDM00959 | CMK | None | 8.4766 |
| SIDM00917 | CESS | None | 11.5699 |
| SIDM00446 | OCI-AML2 | None | 2.9327 |
| SIDM00462 | OCI-AML3 | None | 7.4939 |
| SIDM00428 | NB4 | None | 6.964 |
| SIDM00338 | ME-1 | None | 22.0293 |
| SIDM00437 | MOLM-13 | None | 0.5709 |
| SIDM00461 | OCI-AML5 | None | 4.6842 |
| SIDM00458 | OCI-M1 | None | 4.2151 |
| SIDM00450 | PL-21 | None | 24.6255 |
| SIDM00951 | CTV-1 | None | 0.0007 |
| SIDM00829 | HL-60 | None | 9.8505 |
| SIDM01057 | GDM-1 | None | 0.0097 |
| SIDM00785 | KG-1 | None | 2.5759 |
| SIDM01019 | KMOE-2 | None | 24.0321 |
| SIDM00441 | ML-2 | None | 4.1164 |
| SIDM01023 | MONO-MAC-6 | None | 1.5778 |
| SIDM00576 | NKM-1 | None | 0.4916 |
| SIDM00580 | NOMO-1 | None | 14.6075 |
| SIDM00363 | P31-FUJ | None | 6.4536 |
| SIDM00917 | CESS | None | 0.4882 |
| SIDM00446 | OCI-AML2 | None | 3.8313 |
| SIDM00462 | OCI-AML3 | None | 12.1721 |
| SIDM00338 | ME-1 | None | 20.7203 |
| SIDM00437 | MOLM-13 | None | 0.635 |
| SIDM00458 | OCI-M1 | None | 4.2204 |
| SIDM00461 | OCI-AML5 | None | 9.1392 |
| SIDM00951 | CTV-1 | None | 0.0013 |
| SIDM00829 | HL-60 | None | 17.302 |
| SIDM00594 | HEL | None | 4.7096 |